Friday, June 06, 2014 11:11:44 PM
1. XmAb7195 engages the Fc?RIIb on B-cells to dampen IgE production. Bassil said it would take months to see an effect. Why does it take long? Shouldn't the B-cell be shut down immediately?
2. XmAb7195 engages the Fc?RIIb on liver sinusoidal endothelial cells, targeting IgE bound XmAb7195 to the liver for destruction, which was shown nicely by PET imaging in mice. IgG1 is a nice control, but it is not Xolair, like Bassil eluded to, it does not bind IgE. Bassil stated Xolair does not go to the liver, but I don't see any evidence of that, where is the data?
Recent XNCR News
- Xencor Appoints Bart Cornelissen as Chief Financial Officer • Business Wire • 04/09/2024 12:01:00 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 03/11/2024 07:47:39 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 03/11/2024 07:45:28 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 03/11/2024 07:40:56 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 03/11/2024 07:40:03 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/07/2024 09:10:27 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/07/2024 09:09:08 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/07/2024 09:07:21 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/07/2024 09:05:16 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/07/2024 09:03:28 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/07/2024 09:01:52 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 03/06/2024 07:39:29 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/06/2024 01:32:26 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 03/05/2024 09:48:13 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 03/05/2024 09:34:24 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 03/05/2024 09:27:41 PM
- Xencor to Present at Upcoming Investor Conferences • Business Wire • 02/28/2024 09:01:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/27/2024 09:05:36 PM
- Xencor Reports Fourth Quarter and Full Year 2023 Financial Results • Business Wire • 02/27/2024 09:01:00 PM
- Xencor to Host Webcast to Review Fourth Quarter and Full Year 2023 Financial Results and Provide Vudalimab Clinical Update • Business Wire • 02/20/2024 09:31:00 PM
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 02/16/2024 10:43:57 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/16/2024 09:06:03 PM
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 02/14/2024 11:54:44 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/14/2024 07:23:30 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 02/13/2024 09:07:04 PM
VPR Brands LP Reports Record Annual Financial Performance for Fiscal Year 2023 • VPRB • Apr 19, 2024 11:24 AM
Coinllectibles' Subsidiary, Grand Town Development Limited, Acquires Rare Song Dynasty Ceramics Worth Over USD28million • COSG • Apr 18, 2024 8:03 AM
ILUS Provides Form 10-K Filing Update • ILUS • Apr 17, 2024 9:54 AM
Glucotrack Announces Expansion of Its Continuous Glucose Monitoring Technology to Epidural Glucose Monitoring • GCTK • Apr 17, 2024 8:00 AM
Maybacks Global Entertainment To Fire Up 24 New Stations in Louisiana • AHRO • Apr 16, 2024 1:30 PM
Cannabix Technologies Begins Certification of Contactless Alcohol Breathalyzer, Re-Brands product series to Breath Logix • BLOZF • Apr 16, 2024 8:52 AM